Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain

Nanotechnology

Volumn 21, Issue 33, 2010, Pages

  Kato, Shingo ^a   Itoh, Kyoko ^a   Yaoi, Takeshi ^a   Tozawa, Takenori ^a   Yoshikawa, Yutaka ^b   Yasui, Hiroyuki ^b   Kanamura, Narisato ^a   Hoshino, Akiyoshi ^c   Manabe, Noriyoshi ^c   Yamamoto, Kenji ^c   Fushiki, Shinji ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSENSING; BLOOD CIRCULATION; BLOOD-BRAIN BARRIER; CHRONIC TOXICITY; CLINICAL APPLICATION; EX-VIVO; IN-VIVO; INTRAPERITONEAL ADMINISTRATION; INTRAPERITONEAL INJECTIONS; INTRAPERITONEALLY; LIVE-CELL IMAGING; MODEL SYSTEM; ORGAN DISTRIBUTION; POTENTIAL APPLICATIONS; QUANTUM DOT; QUANTUM DOTS; SPECIFIC DISTRIBUTION; SPECTROMETRIC ANALYSIS; TISSUE LOCALIZATION;

BLOOD; BLOOD VESSELS; CONFOCAL MICROSCOPY; DRUG DELIVERY; LIVER;

SEMICONDUCTOR QUANTUM DOTS;

CAPTOPRIL; LAMININ; QUANTUM DOT;

ANIMAL; ARTICLE; BRAIN; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG DELIVERY SYSTEM; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LIVER; MALE; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOUSE; TISSUE DISTRIBUTION; VASCULARIZATION;

ANIMALS; BRAIN; CAPTOPRIL; DRUG DELIVERY SYSTEMS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; KIDNEY; LAMININ; LIVER; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED ICR; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; QUANTUM DOTS; TISSUE DISTRIBUTION;

EID: 77957837739     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/21/33/335103     Document Type: Article

References (35)

1. Huo Q 2007 Colloids Surf. B 59 1
2. Liu Y, Miyoshi H and Nakamura M 2007 Int. J. Cancer 120 2527
3. Sung J C, Pullliam B L and Edwards D A 2007 Trends Biotechnol. 25 563
4. Hasadsri L, Kreuter J, Hattori H, Iwasaki T and George J M 2009 J. Biol. Chem. 284 6972
5. Larson D R, Zipfel W R, Williams R M, Clark S W, Bruchez M P, Wise F W and Webb W W 2003 Science 300 1434
6. Smith A M and Nie S 2004 Analyst 129 672
7. Jaiswal J K, Mattoussi H, Mauro J M and Simon S M 2003 Nat. Biotechnol. 21 47
8. Parak W J et al 2003 Nanotechnology 14 R15
9. Gao X, Yang L, Petros J A, Marshall F F, Simons J W and Nie S 2005 Curr. Opin. Biotechnol. 16 63
10. Medintz IL, Uyeda H T, Goldman E R and Mattoussi H 2005 Nat. Mater. 4 435
11. Michalet X et al 2005 Science 307 538
12. Hoshino A, Manabe N, Fujioka K, Suzuki K, Yasuhara M and Yamamoto K 2007 J. Artif. Organs 10 149
13. Xing Y and Rao J 2008 Cancer Biomarkers 4 307
14. Bentolila L A, Ebenstein Y and Weiss S 2009 J. Nucl. Med. 50 493
15. Jackson H et al 2007 Neurosurgery 60 524
16. Dahan M, Levi S, Luccardini C, Rostaing P, Riveau B and Triller A 2003 Science 302 442
17. Vu T Q, Maddipati R, Blute T A, Nehilla B J, Nusblat L and Desai T A 2005 Nano Lett. 5 603
18. Slotkin J R et al 2007 Dev. Dyn. 236 3393
19. Hardman R 2006 Environ. Health Perspect. 114 165
20. Nel A, Xia T, Madler L and Li N 2006 Science 311 622
21. http://ec.europa.eu/health/ph-risk/committees/04-scenihr/docs/ scenihr-o-003b.pdf
22. Linkov I et al 2009. J. Nanopart. Res. 11 513
23. Hillyer J F and Albrecht R M 2001 J. Pharm. Sci. 90 1927
24. Akerman M E, Chan W C, Laakonnen P, Bhatia S N and Ruoslahti E 2002 Proc. Natl Acad. Sci. USA99 12617
25. Chen Z et al 2008 Toxicol. Appl. Pharmacol. 230 364
26. Yang R S H et al 2007 Environ. Health Perspect. 115 1339
27. Pardridge W M 2007 Drug Discovery Today 12 54
28. Pardridge W M 2007 Stroke 38 686
29. Koziara J M, Lockman P R, Allen D D and Mumper R L 2003 Pharm. Res. 20 1772
30. Manabe N, Hoshino A, Liang Y Q, Goto T, Kato N and Yamamoto K 2006 IEEE Trans. Nanobiosci. 5 263
31. Ballou B, Lagerholm B C, Ernst L A, Bruchez M P and Waggoner A S 2004 Bioconjug. Chem. 15 79
32. Fischer H C, Liu L, Pang K S and Chan W C W 2006 Adv. Funct. Mater. 16 1299
33. Zhang L W and Monteiro-Riviere N A 2009 Toxicol. Sci. 110138
34. Heikenwalder M, Julius C and Aguzzi A 2007 J. Neurosci. Res. 85 2714
35. Singh S and Nalwa H S 2007 J. Nanosci. Nanotechnol. 7 3048